Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HIVmirror is a biotechnology company specializing in personalized medicine for the management of HIV/AIDS. The company provides a proprietary phenotypic testing service that measures the susceptibility of a patient's specific HIV strain to a wide range of antiretroviral drugs. By evaluating both drug resistance and viral fitness, HIVmirror enables clinicians to design optimized, highly individualized treatment regimens, particularly for patients with multi-drug resistant infections. The platform utilizes a recombinant virus assay to provide precise data on how a patient's virus responds to various therapeutic combinations. Based in Sardinia, Italy, the company operates as a specialized diagnostic provider within the infectious disease sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HIVmirror.